Estado actual del cribado prenatal de cromosomopatías en EspañaResultados encuesta SEQC 2013

  1. María José Alcaine Villarroya 1
  2. Carlos Aulesa Martínez 2
  3. Eva Mª Barrenechea 3
  4. Elena Casals 4
  5. Concepción González Rodríguez 5
  6. Inmaculada Martín Navas 6
  7. Mª Concepción Martínez 7
  8. Paloma Martínez 8
  9. Helena Méndez 8
  10. Mª Belén Prieto García 9
  11. Julia Suárez 10
  12. Elvira Tejedor 11
  1. 1 Hospital Miguel Servet
    info

    Hospital Miguel Servet

    Zaragoza, España

    ROR https://ror.org/01r13mt55

  2. 2 Hospital Val d’Hebrón, Barcelona
  3. 3 Hospital Galdakao-Usansolo, Usansolo, Bizcaia
  4. 4 Hospital Clinic Barcelona
    info

    Hospital Clinic Barcelona

    Barcelona, España

    ROR https://ror.org/02a2kzf50

  5. 5 Hospitales Universitarios Virgen del Rocío y Virgen Macarena, Sevilla
  6. 6 Hospital Universitario Son Espases, Palma de Mallorca
  7. 7 Hospital Clinico Universitario de Valencia
    info

    Hospital Clinico Universitario de Valencia

    Valencia, España

    ROR https://ror.org/00hpnj894

  8. 8 Hospital Universitario La Paz, Madrid
  9. 9 Hospital Universitario Central de Asturias, Oviedo
  10. 10 Hospital General Universitario Gregorio Marañón, Madrid
  11. 11 Hospital Universitari Vall d’Hebrón, Barcelona
Show affiliations +
Journal:
Revista del laboratorio clínico

ISSN: 1888-4008

Year of publication: 2015

Volume: 8

Issue: 3

Pages: 138-148

Type: Article

DOI: 10.1016/J.LABCLI.2015.07.002 DIALNET GOOGLE SCHOLAR

More publications in: Revista del laboratorio clínico

Sustainable development goals

Abstract

During the last 30 years, numerous strategies for prenatal screening of aneuploidies have been developed using sonographic and biochemical markers. In Spain, there were no uniform and global prenatal screening strategies in the different autonomous communities until 2005, when the Sociedad Española de Ginecología y Obstetricia (SEGO) recommended avoiding advanced maternal age as a unique indication for an invasive test and proposed the first trimester combined test implementation. However, there is no evidence yet that a uniform strategy exists. Moreover, the recent advances on genomics have open up the door to the development of new screening strategies based on using fetal DNA recovered from maternal blood. Waiting for objective evidences about the efficacy of these new non-invasive strategies in low-risk population, it would be desirable to know the efficacy of present screening programs to compare them with future strategies and, to pay attention to some recent recommendations in our country. The present work describes the present situation of prenatal screening of aneuploidies in Spain, by analysing data from a survey on 97 public and private centers envolved on chromosomopathies screening in our autonomic communities. With this study, the Prenatal Diagnosis workgroup of the SEQC aims to impulse the coordination and the dialog of all agents implicated into aneuploidies prenatal screening programs in order to achieve a consensued protocol along the different autonomies.

Data source: Dialnet